chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This spontaneous report as received from a registered nurse refers to an unspecified number of patients of unknown age and genders. The reporter stated that, on an unspecified date, an unknown number of doses of LIQUID PEDVAXHIB (dose, lot#, expiration dates not provided) that were stored at 48 degrees F for 20 minutes, then exposed to 47 degrees for 9 minutes have been administered. No adverse effects were reported. Follow up information has been received on 22-JUL-2014 from a receptionist. The reporter stated there were two different lot number of LIQUID PEDVAXHIB that were included in the temperature excursion: Lot # J016188, expiration date: 02-OCT-2016 and lot # J015437, expiration date: 09-OCT-2016. The receptionist did not have any additional information to share. Follow-up information has been received from the registered nurse who provided patients details. This report refers to a 16 months old infant patient of unknown gender. On 19-JUN-2014 the patient was vaccinated with a dose of LIQUID PEDVAXHIB (dose and route were not reported, lot# J016188, expiration date 02-OCT-2016) that was improperly stored. No adverse effects were reported. This is the one of several reports received from the same reporter. Additional information is not expected.
Pt complained of loss of vision in right eye within a week of her TD vaccine. Seen in consultation by an ophthalmologist on 9/8/00. Also started on Ortho Tricyclin in same week.
3/16: Tired late evening, poor sleep overnite. 3/17: Upper body aches and very tired, sleeping a lot during day. Body aches and low fever (99) in evening. Sleeplessness, body aches, mild chills overnight. 3/18: Body aches and tired daytime. Aches and low fever (99-100) in evening. Poor sleep, aches, chills, sweated out (fever?) overnight. 3/19: Felling better daytime. Still some tiredness. Mild body aches. No fever. Better sleep overnight. 3/20-23: General feeling of tiredness but getting better. Have noted some difficulty keeping good  train-of-thought (also noted by spouse). I do have a lot to keep up with. 3/24: Still have a feeling of delayed recovery in general, but improving.
J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/22/2022 CHRONIC HYPOXEMIC RESPIRATORY FAILURE R09.02 HYPOXIA 4/21/2022 CHRONIC HYPOXEMIC RESPIRATORY FAILURE J96.21 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE 4/22/2022 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE R09.02 HYPOXIA 4/21/2022 ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE
Site very painful, sharp pain in upper arm, "feels like needle is in there" (arm).
4-2-2021 acute sinusitis symptoms onset (rhinitis, mild tinnitus, sore throat, Right ear fullness 4-7-2021 progression of above symptoms; 2 a.m. right ear "crackling sounds" with 2 short episodes of sharp pain in right ear (like toothpick jabs), followed with complete fullness, and full loss of hearing 4-7-2021 seen in retail clinic; Dx sinusitis with Rx Augmentin po BID x 10 days 4-9-2021 seen in Urgent Care; Dx otitis media; Rx added ear drops Cipro/dexamethasone 4 gtts BID x 7 days; referral to ENT 4-13-2021 ENT and audiologist Dx: left ear mild hearing loss; right ear severe hearing loss complicated by sinusitis, possible neuro etiology (NONE prior)  I now have no hearing in my right ear.
Patient passed out after receiving the flu shot.  Fortunately, he sat down in a chair before passing out.  I placed my hand on his shoulder and asked him if he was okay and he woke up.  Patient had indicated that he had never had that type of reaction to a vaccine before.  I asked him to remain seated for at least 15 minutes before leaving.  After about 20 minutes, he left the pharmacy and indicated that he was okay.
Within the 15 min waiting period, patient began to experience blurred vision and subjective dizziness.  He subsequently also developed significant pain at the injection site without redness/swelling/erythema and complaint of diffuse myalgias. Arm pain now resolved but lasted 2 weeks.  Myalgias and blurred vision complaints persist today (>2 wks later).  He has also been having an exacerbation of his chronic migraines over the last 2 weeks.
little bit of pain at the injection site; heart racing; Blood pressure of 163/n/a/could feel the high blood pressure in head and throughout the body; itchy chest; red dots under skin on chest as if rash is about to form; rash on face; face being warm; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (little bit of pain at the injection site), PALPITATIONS (heart racing), BLOOD PRESSURE ABNORMAL (Blood pressure of 163/n/a/could feel the high blood pressure in head and throughout the body), PRURITUS (itchy chest) and ERYTHEMA (red dots under skin on chest as if rash is about to form) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Breast cancer (previous breast cancer patient,(occurred 20 years ago).). Concurrent medical conditions included Asthma (Patient has severe asthma). Concomitant products included SALBUTAMOL (ALBUTEROL HFA) for an unknown indication.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced VACCINATION SITE PAIN (little bit of pain at the injection site), PALPITATIONS (heart racing), BLOOD PRESSURE ABNORMAL (Blood pressure of 163/n/a/could feel the high blood pressure in head and throughout the body), PRURITUS (itchy chest), ERYTHEMA (red dots under skin on chest as if rash is about to form), RASH (rash on face), FEELING HOT (face being warm) and DIZZINESS (dizziness). At the time of the report, VACCINATION SITE PAIN (little bit of pain at the injection site), PALPITATIONS (heart racing), BLOOD PRESSURE ABNORMAL (Blood pressure of 163/n/a/could feel the high blood pressure in head and throughout the body), PRURITUS (itchy chest), ERYTHEMA (red dots under skin on chest as if rash is about to form), RASH (rash on face), FEELING HOT (face being warm) and DIZZINESS (dizziness) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: 163/n/a..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
approx 2-3hr p/vax pt became dizzy & passed out; taken to ER& tx;
On August 25, 2008 patient began having vesicles wich began to spread over the entire body over the next few days. Symptoms are condsistent with the Chickenpox. Supportive treatment was reccomended.
Hives on behind the right thigh, itchy and hot approximately 1 hour after the vaccination. Left upper arm soreness for 4 days. Extreme exhaustion that lasted for 3 days.
Next day got hives (red) (Hives to torso, arms, feet) itchy wrists, temp.
No adverse reaction @ time of administrating vx. Pt was administered wrong supply of vaccine. Was administered proquad which is not recommended for pt's age.
10-15 mins after flu shot, pt in car with father and brother who report he c/o numbness in one arm, then LOC, gagging resps, Tonic/Clonic generalized movements approximately 30 secs. Pt amnesic for events.
Sore arm. Low grade fever next day and light head ness. Felt anxiety and muscle aches.
Near death; This case was reported by a consumer via interactive digital media and described the occurrence of adverse event in a patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season at an unknown dose. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced adverse event. On an unknown date, the outcome of the adverse event was unknown.   It was unknown if the reporter considered the adverse event to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were provided as follows: The age at vaccination was not reported. The patient almost died from flu vaccine and reported that it save some and kills some.
4 hours after the shot the patient developed an injection site reaction in the deltoid that hurt all the way down to the elbow for 4 days
Paralyzed her legs; This case was reported by a consumer via interactive digital media and described the occurrence of paralysis legs in a female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent unspecified season) for prophylaxis.   On an unknown date, the patient received Influenza vaccine Quadrivalent unspecified season. On an unknown date, unknown after receiving Influenza vaccine Quadrivalent unspecified season, the patient experienced paralysis legs (serious criteria GSK medically significant). On an unknown date, the outcome of the paralysis legs was unknown.   The reporter considered the paralysis legs to be related to Influenza vaccine Quadrivalent unspecified season.  Additional details were reported as follows: The age at vaccination was not reported. The patient had no no any issues either, untill she got flu shot and it paralyzed her legs. This case is one of the 4 cases reported by same reporter out of which 2 were invalid.; Sender's Comments:  US-GLAXOSMITHKLINE-US2020AMR225484:same reporter US-GLAXOSMITHKLINE-US2020AMR225504:same reporter US-GLAXOSMITHKLINE-US2020AMR225505:same reporter
pt returned to student hlth center to report cont tenderness deltoid area;also stated that bruising approx 7 1/2-8" below site appeared next day;no discoloration, no swelling, no heat @ site;
Right after the shot my shoulder swelled up so bad I was in severe pain. I took ibuprofen. It subsided but it now is getting worse. I know something is wrong in there but, I can't afford to go get it diagnosed at an orthopedic. It become disabling, I can hardly do anything. I can't even sleep on my right side anymore.
This spontaneous report as received from a other health professional refers to patients of unknown age and gender. On unknown dates, the patients were vaccinated with ZOSTAVAX lot # N012615, for prophylaxis. Concomitant therapies included sterile diluent(STERILE DILUENT). On unknown dates, the patients experienced incorrect product storage and no adverse event. The outcome of incorrect product storage and no adverse event were unknown. The reporter considered incorrect product storage and no adverse event to be not related to ZOSTAVAX. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1708USA011266: US-009507513-1708USA011267:
5 minutes after receiving vaccinations, patient began grunting, wheezing on expiration. Dusky color of face and lips. Oxygen given at 10L/min per mash. Albuterol aerosol treatment given. Epinephrine 0.3mg given SQ. BP 150/80, Pulse - 88, Saturated oxygen 97%. Transported to ER via ambulance. Diagnosed with allergic reaction and hypokalemia.
This spontaneous report has been received from a registered nurse referring to a patient of unknown age and gender. The patient's pertinent medical history and concurrent conditions were not provided. On 08-FEB-2016, the patient was vaccinated with a improperly stored VAQTA, time frame 16 hours, a temperature of 34F, (strength, dose, route, and frequency were not provided) (lot# reported as L026037, expiration date 17-JAN-2018). Concomitant therapies were not provided. The registered nurse did not reported adverse effects. No product quality complaint was reported. This is one of two reports from the same reporter. Additional information has been requested.
Came in for a routine flu vaccine, was inadvertently given the Pfizer COVID-19 vaccine instead. Patient had already received two doses of the Moderna vaccine in the past, however this dose *was* roughly six months after her second Moderna dose.  Patient did not exhibit any unusual adverse effects for the shot (reported soreness), but we are reporting in an abundance of caution.
Greater discomfort than usual at time of vaccine administration; later experienced pain radiating to shoulder and upper back and chest; later experienced pain from shoulder to hand.  Evaluated in person by health care provider on 11/24/14, 12/1/14 and by phone by health care provider on 12/10/14.
unable to eat anything; vomiting; extreme headache; extreme fatigue; nausea; temperature of 101.4 F; This spontaneous report as received from a consumer referring to her daughter a 14 years old patient. Patient's medical history and concomitant medications were reported as none. Information regarding drug allergies or reactions was not provided.   On 24-NOV-2020, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) for vaccination against cervical cancer (prophylaxis) (strength, dose, lot number and expiration date were not provided). .         On 26-NOV-2020,  the patient experienced an extreme headache, extreme fatigue, nauseas, vomiting, temperature of 101.4 Fahrenheit (fever) and is unable to eat anything (feeding disorder).  To address the fatigue the patient was resting and she received paracetamol (TYLENOL) and ibuprofen (MOTRIN) to treat the headache and fever.  The outcome of feeding disorder, pyrexia, nausea, fatigue, headache and vomiting was reported as not recovered/not resolved. At the reporting time it was unknown if the patient would follow the vaccination scheme.  The reporter did not assess the causal relationship between the events and the suspect vaccine.
0-12 hours after vaccine - Arm pain 12-18 hours after - Began to feel feverish, chills, headache, temperature 99.1 18-36 hours after - Temperature rose to 102 approximately 24 hours after vaccine, chills and aches in head, neck, and jaw, severe arm pain, began using Tylenol every 6 hours 36-72 hours after - Temperature down to 99.5 without medication, large raised red welt formed on arm at injection site, arm is still painful
he's developing a cat allergy; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old male patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on 14Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient stated that in his life he had never developed any allergies, he works in a house where they have a couple of cats, he was always surrounded by animals but has never had any allergy. Since Monday (on 19Apr2021) when he started working there, he has been feeling like he was developing a cat allergy or who knows to what, but he has never experienced allergy symptoms before, did the vaccine wake up an allergy gene. The patient was considering not getting the second dose. The outcome of the event was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Employee reported on 7/10/2012 onset of symptoms on 7/7/2012 of pain in eyes and with motion, myalgia, and observed rash on 7/9/2012 on trunk and extremities. Received MMR 12 days before symptom onset.
Patient received Pfizer COVID vaccine on 3/5/21 (lot # EN6204), 3/30/21 (lot # ER8732), and 1/3/22 (lot # FJ1611).  On 1/22/23, patient admitted to our inpatient facility (med/surg unit) with acute respiratory failure with hypoxia, Covid-19 pneumonia with possible superimposed bacterial pneumonia, syncope, and AKI on CKD3. Patient discharged home on 1/26/23.
Developed headache 1 1/2 hours after vaccination similar to sinus pressure. Two hours after vaccination began feeling itchy including her tongue. She took 50mg of Benadryl which helped within 45 minutes. Headache  dissipated by 1:30pm.
Blood and mucus from rectum, abdominal cramping, bloating and pain.  Diagnosed with ulcerative colitis and is currently on hydrocortisone enemas qd, Melamine rectal suspension qd and Pentasa 500mg two capsules by mouth three times daily.
Patient developed sudden onset right sided sensorineural hearing loss two days after receiving routine vaccines at well visit.
left cerebral hemispheric stoke; transient ischemic attack; This initial spontaneous information was received from a lawyer regarding a case in litigation and refers to a female patient of unknown age. On or about 09-FEB-2017, the patient was inoculated with zoster vaccine live (ZOSTAVAX) for routine health maintenance and for its intended purpose: the prevention of shingles (herpes zoster). Shortly after, the patient suffered left sided numbness and weakness. The patient was hospitalized and diagnosed with left cerebral hemispheric stroke and transient ischemic attack. As a direct and proximate result of zoster vaccine live (ZOSTAVAX), the patient's symptoms have resulted in physical limitations not present prior to using the product. The patient also experiences mental and emotional distress due to resulting physical limitations and seriousness of her condition. As a result of manufacture, marketing, advertising, promotion, distribution and/or sale of zoster vaccine live (ZOSTAVAX), the patient sustained severe and permanent personal injuries. Further, as a tragic consequence of the Company's wrongful conduct, the patient suffered serious, progressive, permanent, and incurable injuries, as well as significant conscious pain and suffering, mental anguish, emotional distress, loss of enjoyment of life, physical impairment and injury. As a direct and proximate result of the Company's conduct, the patient has suffered and incurred damages, including medical expenses; the loss of accumulations; and other economic and non-economic damages. The outcome of the events was considered not recovered/not resolved. The events were considered to be related to zoster vaccine live (ZOSTAVAX).  Upon internal review, left cerebral hemispheric stroke and transient ischemic attack were considered to be medically significant. Left cerebral hemispheric stroke and transient ischemic attack were considered to be disabling.
A delayed reaction rash occured. The rash covered the better part of hias entire upper arm. It started off as a small bumb according to his mother. My observations showed a light pink rash along his bicep and a darker rad outlining on the bottom of the border of the rash. The spoke to the PCP last night and were told to put a warm compress on it and take tylenol and benadryl as needed. Today they got a prescription for cephalexin 250mg three times daily for 10 days and are going to see the PCP tomorrow in person.
PUNCTURED VIAL BACK WHICH REMAINED IN THE REFRIGERATOR OVERNIGHT AND WAS USED IN A PATIENT; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 30-JUL-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 30-JUL-2021, the subject experienced punctured vial back which remained in the refrigerator overnight and was used in a subject. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of punctured vial back which remained in the refrigerator overnight and was used in a patient was not reported. This report was non-serious.
Client weak when leaving, following vaccine administration, noticed staggering in hallway to exit for observation area.  Placed in chair, eyes open, able to say name and nod yes/no to questions.  Responded saying had no food this am prior to vaccine administration.  Mother reports not ill, no chronic illnesses.    Diaphoretic.  B/P: #1:90/40, #2: 100/40.  Client head lowered, cool compress to neck, slow fan to face.  Client slowly recovered after 45 minutes observation and care.  Was oriented, able to answer questions.  Advised mother to feed client prior to activities of the rest of the day.  Mother voiced understanding.  Client able to walk out of building and leave with his mother in the car.
Havent menstruated since 09/2020. Have had hot flashes for months/years. Hot flashes ceased within couple of weeks of second vaccine. Started menstruation on 6/16/2021. Flow became very heavy at times with cramping.
Nausea, weakness, diarrhea, stomach cramps, hands shaky, occ dizziness, feel "really hot". Temp unknown.
Patient reports tingling in hand and fingers about 2 hours following vaccination. There was no change in color. Tingling went away since
Injection site reactions of redness; Injection site reactions of redness, swelling; Injection site reactions of redness, swelling and warm to touch; This case was reported by a consumer via call center representative and described the occurrence of injection site erythema in a 65-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   Concurrent medical conditions included fish allergy.   On 4th March 2020, the patient received the 1st dose of Shingrix. On an unknown date, less than 6 months after receiving Shingrix, the patient experienced injection site erythema, injection site swelling and injection site warmth. The patient was treated with prednisone. Shingrix was discontinued. On an unknown date, the outcome of the injection site erythema, injection site swelling and injection site warmth were unknown.   It was unknown if the reporter considered the injection site erythema, injection site swelling and injection site warmth to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The reporter was the patient.  The patient asked if the Shingrix vaccine conatin fish. The patient had her first dose of Shingrix and experienced injection site reactions of redness, swelling and warm to touch. The physician prescribed Prednisone. Follow up was delayed due to the outbreak of the COVID-19 pandemic.  The patient was followed up for her 2nd dose with her HCP and he indicated not to get the 2nd dose. The patient would follow up with HCP.  The reporter consented to follow up.
01/2021 1st vaccine, 02/2021 2nd vaccine, 12/2021 Booster- 08/2021 TIA.
Hives, fever, chills, migraines, myalgia's, sore arm
DECEMBER 27TH TESTED POSTIVE WITH RAPID ANTIGEN KIT.  COVID 19 SYMPTOMATIC.  MODERATE FLU SYMPTOMS.
Extreme fussy and fever to 102.4 within 24 hours of 4 mo vaccine-advise split 6 mo vaccines- DTap, polio, Hep B, Prevnar- each given at separate visits. Treatment was supportive care measures for symptoms.
This case was reported by a nurse to a sales representative and described the occurrence of an injection site reaction in a child who received diphtheria and tetanus toxoids and acellular pertussis vaccine absorbed for prophylaxis. On an unspecified date, the patient received either the 18 month or 4 year dose of Infanrix. At an unspecified time post immunization, the patient developed an injection site reaction characterized by swelling and redness. The outcome of the event was unknown. Comment: The reporter indicated that three additional patient's experienced the same events following receipt of Infanrix during the same week. Each patient received the 18 month  or 4 year dose of vaccine. Identifiers are currently available for only one of these three patients.